Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2003
The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanismMichael Engel, Torsten Hoffmann, Leona Wagner, et al.Journal of Medicinal Chemistry|June 2, 2021
An Exploration of Chemical Properties Required for Cooperative Stabilization of the 14-3-3 Interaction with NF-κB-Utilizing a Reversible Covalent Tethering ApproachMadita Wolter, Dario Valenti, Peter J Cossar, et al.Angewandte Chemie (International Ed. in English)|August 21, 2020
Fragment-Based Stabilizers of Protein-Protein Interactions through Imine-Based TetheringMadita Wolter, Dario Valenti, Peter J Cossar, et al.Journal of Molecular Biology|November 29, 2007
Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanismYue Xu, Yoshitaka Nakajima, Kiyoshi Ito, et al.Neurobiology of Aging|September 28, 2011
No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's diseaseAntje Hillmann, Stefanie Hahn, Stephan Schilling, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjectsInge Lues, Frank Weber, Antje Meyer, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Postnatal life events affect the severity of asthmatic airway inflammation in the adult ratCarsten Kruschinski, Thomas Skripuletz, Sammy Bedoui, et al.Neuropeptides|March 19, 2016
Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulationLeona Wagner, Florian Kaestner, Raik Wolf, et al.Journal of Neurochemistry|July 17, 2008
Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situStephan Schilling, Thomas Appl, Torsten Hoffmann, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2010
Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligandsJens-Uwe Peters, Torsten Hoffmann, Patrick Schnider, et al.Pageof 8